1. United States
2. Minn.
3. Letter

Cancer research faces deep polarization due to federal budget cuts and the politicization of NIH and NCI grants. Advocates and oncologists maintain that medical breakthroughs rely on objective, evidence-based science and argue that treating the disease should transcend political divides.The debate encompasses several facets:Federal Funding Cuts & Reallocations: The administration has proposed and implemented cuts to NIH and NCI budgets, alongside mandates forcing political appointees to review grants against federal policy priorities. Critics warn this jeopardizes critical clinical trials and pushes young researchers out of the field.Restriction on Research Topics: Funding has been heavily scrutinized or terminated for specific demographics. Studies examining cancers in sexual and gender minority individuals, along with research into diversity and gender, have faced particular restriction.Bipartisan Pushback: Politicians, advocates, and researchers argue that cancer "does not care about politics" and crosses all party lines. Many medical professionals are urging Congress to pass legislation to protect NIH grant agreements and shield scientific inquiry from sudden political mandates. Do not make cancer research political. Keep it with the scientists and under peer review. Block the proposed law to change this.